• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

对超广谱头孢菌素敏感性降低的淋病奈瑟菌菌株。

Neisseria gonorrhoeae strain with reduced susceptibilities to extended-spectrum cephalosporins.

作者信息

Nguyen Duylinh, Gose Severin, Castro Lina, Chung Kathleen, Bernstein Kyle, Samuel Micheal, Bauer Heidi, Pandori Mark

出版信息

Emerg Infect Dis. 2014 Jul;20(7):1211-3. doi: 10.3201/eid2007.131396.

DOI:10.3201/eid2007.131396
PMID:24964277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4073858/
Abstract

The spread of Neisseria gonorrhoeae strains with reduced susceptibility to extended-spectrum cephalosporins is an increasing public health threat. Using Etest and multiantigen sequence typing, we detected sequence type 1407, which is associated with reduced susceptibilities to extended-spectrum cephalosporins, in 4 major populated regions in California, USA, in 2012.

摘要

对超广谱头孢菌素敏感性降低的淋病奈瑟菌菌株的传播对公共卫生构成了日益严重的威胁。2012年，我们在美国加利福尼亚州的4个主要人口密集地区，使用Etest和多抗原序列分型方法，检测到了与超广谱头孢菌素敏感性降低相关的序列类型1407。

相似文献

1
Neisseria gonorrhoeae strain with reduced susceptibilities to extended-spectrum cephalosporins.对超广谱头孢菌素敏感性降低的淋病奈瑟菌菌株。
Emerg Infect Dis. 2014 Jul;20(7):1211-3. doi: 10.3201/eid2007.131396.
2
Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.加利福尼亚的淋病奈瑟菌和扩展谱头孢菌素：马赛克 penA 的监测和分子检测。
BMC Infect Dis. 2013 Dec 4;13:570. doi: 10.1186/1471-2334-13-570.
3
Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.在日本，由国际多重耐药性淋病奈瑟菌ST1407菌株引起的淋病，使用2克阿奇霉素（缓释制剂）治疗失败。
J Antimicrob Chemother. 2014 Aug;69(8):2086-90. doi: 10.1093/jac/dku118. Epub 2014 Apr 28.
4
Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.2009年至2013年阿根廷对超广谱头孢菌素敏感性降低的淋病奈瑟菌分离株的出现与传播
Sex Transm Dis. 2017 Jun;44(6):351-355. doi: 10.1097/OLQ.0000000000000603.
5
[Antimicrobal resistance of Neisseria gonorrhoeae strains in Hungary].[匈牙利淋病奈瑟菌菌株的抗菌耐药性]
Orv Hetil. 2015 Feb 8;156(6):226-9. doi: 10.1556/OH.2015.30079.
6
Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014-2016: focus on extended-spectrum cephalosporins and azithromycin.2014-2016 年爱尔兰淋病奈瑟菌全基因组测序的抗菌药物耐药性和分子流行病学研究：重点关注头孢菌素类和阿奇霉素的扩展谱。
Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1661-1672. doi: 10.1007/s10096-018-3296-5. Epub 2018 Jun 7.
7
Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011-16.2011-2016 年阿根廷对头孢菌素类抗生素的敏感性和耐药性降低的淋病奈瑟菌分离株的基于基因组的流行病学和抗菌药物耐药决定因素。
J Antimicrob Chemother. 2019 Jun 1;74(6):1551-1559. doi: 10.1093/jac/dkz054.
8
Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins.淋球菌成功国际克隆株的基因组测序，该克隆株对头孢菌素类抗生素的敏感性和耐药性降低。
Antimicrob Agents Chemother. 2012 Nov;56(11):5633-41. doi: 10.1128/AAC.00636-12. Epub 2012 Aug 20.
9
Cephalosporin-Resistant Neisseria gonorrhoeae Clone, China.头孢菌素耐药淋病奈瑟菌克隆，中国。
Emerg Infect Dis. 2018 Apr;24(4):804-806. doi: 10.3201/eid2404.171817.
10
Antimicrobial susceptibilities and molecular typing of neisseria gonorrhoeae isolates at a medical centre in Taiwan, 2001-2013 with an emphasis on high rate of azithromycin resistance among the isolates.2001-2013 年台湾某医学中心淋病奈瑟菌分离株的药敏试验和分子分型研究，重点关注分离株中阿奇霉素耐药率较高的情况。
Int J Antimicrob Agents. 2018 May;51(5):768-774. doi: 10.1016/j.ijantimicag.2018.01.024. Epub 2018 Apr 3.

引用本文的文献

1
Molecular Regulatory Mechanisms Drive Emergent Pathogenetic Properties of .分子调控机制驱动……的新兴致病特性 。（原文句子不完整）
Microorganisms. 2022 Apr 28;10(5):922. doi: 10.3390/microorganisms10050922.
2
Global Network Analysis of Neisseria gonorrhoeae Identifies Coordination between Pathways, Processes, and Regulators Expressed during Human Infection.淋病奈瑟菌的全球网络分析确定了人类感染期间表达的途径、过程和调节因子之间的协调作用。
mSystems. 2020 Feb 4;5(1):e00729-19. doi: 10.1128/mSystems.00729-19.
3
Human Factor H Domains 6 and 7 Fused to IgG1 Fc Are Immunotherapeutic against .人因子 H 结构域 6 和 7 融合到 IgG1 Fc 中具有免疫治疗作用，可对抗 。
J Immunol. 2018 Nov 1;201(9):2700-2709. doi: 10.4049/jimmunol.1701666. Epub 2018 Sep 28.
4
Transcriptome Analysis of Neisseria gonorrhoeae during Natural Infection Reveals Differential Expression of Antibiotic Resistance Determinants between Men and Women.自然感染淋病奈瑟菌转录组分析显示男女之间抗生素耐药决定因素的差异表达。
mSphere. 2018 Jun 27;3(3). doi: 10.1128/mSphereDirect.00312-18. Print 2018 Aug 29.
5
Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014-2016: focus on extended-spectrum cephalosporins and azithromycin.2014-2016 年爱尔兰淋病奈瑟菌全基因组测序的抗菌药物耐药性和分子流行病学研究：重点关注头孢菌素类和阿奇霉素的扩展谱。
Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1661-1672. doi: 10.1007/s10096-018-3296-5. Epub 2018 Jun 7.
6
Molecular epidemiology of Neisseria gonorrhoeae strains circulating in Indonesia using multi-locus variable number tandem repeat analysis (MLVA) and Neisseria gonorrhoeae multi-antigen sequence typing (NG-MAST) techniques.采用多位点可变数目串联重复分析（MLVA）和淋病奈瑟菌多抗原序列分型（NG-MAST）技术对印度尼西亚流行的淋病奈瑟菌菌株进行分子流行病学研究。
BMC Infect Dis. 2018 Jan 5;18(1):7. doi: 10.1186/s12879-017-2940-5.
7
Performance and Verification of a Real-Time PCR Assay Targeting the gyrA Gene for Prediction of Ciprofloxacin Resistance in Neisseria gonorrhoeae.靶向gyrA基因的实时荧光定量PCR检测法在预测淋病奈瑟菌对环丙沙星耐药性中的性能及验证
J Clin Microbiol. 2016 Mar;54(3):805-8. doi: 10.1128/JCM.03032-15. Epub 2016 Jan 6.
8
Draft Genome Sequence of Neisseria gonorrhoeae Sequence Type 1407, a Multidrug-Resistant Clinical Isolate.淋病奈瑟菌序列类型1407的基因组序列草图，一种多重耐药临床分离株
Genome Announc. 2015 Aug 13;3(4):e00903-15. doi: 10.1128/genomeA.00903-15.
9
The Gonococcal Transcriptome during Infection of the Lower Genital Tract in Women.女性下生殖道感染期间的淋球菌转录组
PLoS One. 2015 Aug 5;10(8):e0133982. doi: 10.1371/journal.pone.0133982. eCollection 2015.

本文引用的文献

1
Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study.美国对头孢克肟敏感性降低的淋病奈瑟菌的基因组流行病学：一项回顾性观察研究。
Lancet Infect Dis. 2014 Mar;14(3):220-6. doi: 10.1016/S1473-3099(13)70693-5. Epub 2014 Jan 22.
2
Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.淋病奈瑟菌对头孢菌素类药物的敏感性降低：来自 2007-2011 年英格兰和威尔士淋球菌对抗微生物药物耐药性监测计划（GRASP）的数据。
Lancet Infect Dis. 2013 Sep;13(9):762-8. doi: 10.1016/S1473-3099(13)70143-9. Epub 2013 Jun 11.
3
Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.南非首例和第二例对头孢克肟治疗失败的耐头孢菌素淋病奈瑟菌感染的表型和遗传特征及其与头孢克肟治疗失败的关系。
J Antimicrob Chemother. 2013 Jun;68(6):1267-70. doi: 10.1093/jac/dkt034. Epub 2013 Feb 14.
4
CDC Grand Rounds: the growing threat of multidrug-resistant gonorrhea.疾病预防控制中心例会：日益严重的耐多药淋病威胁。
MMWR Morb Mortal Wkly Rep. 2013 Feb 15;62(6):103-6.
5
Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone.在欧洲淋球菌抗菌药物耐药监测项目中进行的分子流行病学分型显示，一种多重耐药克隆占据主导地位。
Euro Surveill. 2013 Jan 17;18(3):20358.
6
Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011.2011 年越南淋病奈瑟菌分离株的药敏和遗传特征。
BMC Infect Dis. 2013 Jan 25;13:40. doi: 10.1186/1471-2334-13-40.
7
Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.加拿大多伦多地区淋病奈瑟菌治疗失败及对头孢克肟的敏感性。
JAMA. 2013 Jan 9;309(2):163-70. doi: 10.1001/jama.2012.176575.
8
Update on Emerging Infections: news from the Centers for Disease Control and Prevention. Update to the CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections .新发传染病最新情况：来自疾病控制与预防中心的消息。2010年美国疾病控制与预防中心性传播疾病治疗指南更新：口服头孢菌素不再是淋球菌感染的推荐治疗药物。
Ann Emerg Med. 2013 Jan;61(1):91-5. doi: 10.1016/j.annemergmed.2012.10.015.
9
The threat of untreatable gonorrhoea: implications and consequences for reproductive and sexual morbidity.无法治愈的淋病的威胁：对生殖和性健康疾病的影响及后果
Reprod Health Matters. 2012 Dec;20(40):76-82. doi: 10.1016/S0968-8080(12)40653-X.
10
Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.加拿大对头孢曲松和头孢克肟敏感性降低的淋病奈瑟菌分离株的出现和特征：2001-2010 年。
Sex Transm Dis. 2012 Apr;39(4):316-23. doi: 10.1097/OLQ.0b013e3182401b69.